Operator
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company s request.
I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead.
Lauren Stival
Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s first quarter 2021 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation 2021 first-quarter financial results and corporate update conference call. [Operator instructions] Please be advised that today s conference is being recorded. [Operator instructions]. I would now like to hand the conference to your speaker host today, Pam Murphy.
Please go ahead.
Investor Relations Consultant
Thank you, and good morning. On the call from Arbutus executive team are Bill Collier, president and chief executive officer; Dave Hastings, chief financial officer; Dr. Gaston Picchio, chief development officer; and Dr. Mike Sofia, chief scientific officer.
Bill will begin with the review of the first quarter s accomplishment, clinical development, and remaining 2021 corporate objectives; followed by Dave Hastings, who will provide a the review of the company s first quarter financial results. We ll then open up the call for Q&A. Mike and Gaston will be available to
Operator
Good morning, ladies and gentlemen. Thank you for standing by and welcome to the Agenus Fourth Quarter 2020 Conference Call and Webcast. [Operator Instructions] Please note that this event is being recorded and may be used in future Agenus promotional material.
I would now like to turn the conference over to Jan Medina, Director of Investor Relations. Jan, please go ahead.
Jan Medina
Thanks, Liz, and thank you, all, for joining us today.
Today s call is being webcast and will be available on our website for replay. Before we start, I just want to quickly introduce myself. I now have spoken with a number of you already over the last month or so, but I started year here at Agenus back in February to help lead the investor relations efforts. Certainly, it s a very promising time for the Company. I m looking forward to being part of the conversations we re having with the investment community.
Arbutus Biopharma (ABUS) Q4 2020 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.